Sify Swings to Small Profit in Q2 FY27 as Revenue Scales

What happened

Sify reported Q2 FY2026-27 revenue of INR 13,798 million, up sharply from INR 11,596 million in the prior quarter, with adjusted EBITDA of INR 3,131 million and a profit of INR 40 million. The positive net income, though minimal, marks a turnaround from the INR 329 million loss in the December 2025 quarter, but the absolute figure is too small to signal durable profitability. The revenue jump likely reflects data center capacity commissions and conversion of sold MW into revenue, consistent with management's earlier commentary on contracted go-lives. However, the press release omits key details such as interest expense, borrowings, capex, and cash position, leaving investors unable to assess whether the funding pressure described in the prior report has eased. Without confirmation on leverage reduction or the SISL IPO progress, this quarter's profit does not fundamentally resolve the balance-sheet risk that underpins the WAIT rating.

Implication

The positive bottom line removes immediate insolvency fear but does not address the core risk of high leverage and capex funding needs. If revenue growth is driven by new data center capacity, the next quarters must show that sold MW remains tight against ready-for-service MW to justify continued expansion. The absence of debt and capex details in the press release makes it impossible to verify whether the SISL IPO proceeds have been applied or whether borrowings have declined from the INR 39,593 million reported as of December 2025. Investors should wait for the full financial statements and management commentary to assess interest coverage, cash burn, and funding progress before adding positions. Attractive entry remains near $12; current price likely above that, and without a clear deleveraging catalyst, the risk/reward is still unfavorable.

Thesis delta

The Q2 profit is a positive data point but does not alter the central thesis that funding execution and absorption timing dominate the investment case. The report lacks the granular balance-sheet data needed to confirm de-risking, so the WAIT rating and $12 attractive entry remain unchanged. The threshold for a thesis upgrade remains a launched/priced SISL IPO or clear evidence that borrowings have stopped rising relative to EBITDA.